Heme detoxification and hemozoin formation machinery

The heme detoxification machinery in Plasmodium falciparum is a vital metabolic process that allows the malaria parasite to survive while consuming host hemoglobin during its blood-stage infection (Jani et al., 2008). As hemoglobin is proteolytically degraded in the parasite's acidic digestive vacuole, it releases free heme (ferriprotoporphyrin IX), a redox-active molecule that is highly toxic to the parasite's membranes and enzymes (Egan, 2008). To prevent cellular damage, the parasite utilizes a specialized machinery—involving the Heme detoxification protein (HDP), lipids, and potentially histidine-rich proteins—to sequester free heme into an inert, crystalline polymer called hemozoin (Sullivan et al., 1996). This biocrystallization pathway is the pharmacological target of several major antimalarial drug classes, including 4-aminoquinolines like chloroquine and quinoline methanols like quinine (Weissbuch & Leiserowitz, 2008). These drugs bind to heme or the growing crystal surface, halting detoxification and leading to a lethal buildup of free heme within the parasite. Because this process is unique to the parasite and absent in human physiology, it remains one of the most effective targets for antimalarial therapy, although its efficacy is increasingly challenged by the evolution of drug efflux transporters like PfCRT (PubMed, 2023).

Other names

Hemozoin formation pathwayHeme biocrystallization machineryHeme sequestration pathwayMalaria pigment formationHeme detoxification protein (HDP)Ferriprotoporphyrin IX sequestration

Inhibition of the conversion of toxic free heme into non-toxic hemozoin crystals, leading to heme-mediated oxidative damage and parasite death (Egan, 2008; Weissbuch & Leiserowitz, 2008).